MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Exagen Depreciation & Amortization 2011-2026 | XGN
Annual Depreciation & Amortization Exagen
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.2 M | 1.6 M | 900 K | 500 K | 600 K | 600 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.2 M | 500 K | 1.07 M |
Quarterly Depreciation & Amortization Exagen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 600 K | 500 K | 400 K | - | 400 K | 400 K | 500 K | - | 600 K | 500 K | 600 K | - | 400 K | 300 K | 300 K | - | 300 K | 200 K | 200 K | - | 100 K | 200 K | 100 K | - | 100 K | 200 K | 200 K | - | 200 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 600 K | 100 K | 332 K |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 20.8 | 0.85 % | $ 226 M |  China |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
1.23 M | $ 0.17 | -5.26 % | $ 4.99 M | USA |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.52 | 1.2 % | $ 1.93 M | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 39.06 | -0.64 % | $ 1.08 B | USA |
 |
Danaher Corporation
DHR
|
721 M | $ 229.23 | -0.65 % | $ 168 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 10.98 | 2.62 % | $ 312 M |  Israel |
 |
DexCom
DXCM
|
186 M | $ 66.52 | -0.81 % | $ 25.7 B | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
120 M | $ 101.86 | -0.04 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 26.19 | -1.13 % | $ 792 M | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
CareDx, Inc
CDNA
|
14.4 M | $ 18.93 | -0.73 % | $ 1.02 B | USA |
 |
Celcuity
CELC
|
130 K | $ 99.58 | -0.34 % | $ 3.93 B | USA |
 |
Anixa Biosciences
ANIX
|
38.3 K | $ 3.13 | 0.32 % | $ 99.8 K | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
42.4 M | $ 102.21 | 1.6 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | USA |
 |
IQVIA Holdings
IQV
|
1.11 B | $ 225.57 | -0.92 % | $ 40.9 B | USA |
 |
ENDRA Life Sciences
NDRA
|
46.5 K | $ 4.45 | -6.62 % | $ 2.39 M | USA |
 |
Illumina
ILMN
|
354 M | $ 130.74 | -1.51 % | $ 20.8 B | USA |
 |
Charles River Laboratories International
CRL
|
362 M | $ 200.01 | -0.93 % | $ 10.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
493 M | $ 173.69 | -1.03 % | $ 19.3 B | USA |
|
Biodesix
BDSX
|
5.77 M | $ 6.75 | 0.45 % | $ 875 M | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
644 M | $ 251.26 | -0.72 % | $ 21.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 181.71 | -0.7 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
130 M | $ 676.07 | -0.92 % | $ 55.8 B | USA |
 |
Lantheus Holdings
LNTH
|
64.6 M | $ 66.81 | -0.52 % | $ 4.62 B | USA |
 |
Mettler-Toledo International
MTD
|
50.4 M | $ 1 396.59 | -1.25 % | $ 29.6 B |  Schweiz |
 |
Agilent Technologies
A
|
321 M | $ 136.49 | -0.81 % | $ 41.5 B | USA |
 |
Myriad Genetics
MYGN
|
61.2 M | $ 6.12 | -0.89 % | $ 554 M | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.5 | 2.04 % | $ 5.74 M | USA |
 |
Bioventus
BVS
|
57.4 M | $ 7.44 | -0.13 % | $ 466 M | USA |
 |
QIAGEN N.V.
QGEN
|
203 M | $ 45.03 | -0.64 % | $ 10 B |  Niderland |
 |
NeoGenomics
NEO
|
39.1 M | $ 11.82 | -3.35 % | $ 1.5 B | USA |